Article
Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
Breast cancer research and treatment - 1 Feb 2020
Tynan Mara, Peshkin Beth N, Isaacs Claudine, Willey Shawna, Valdimarsdottir Heiddis B, Nusbaum Rachel, Hooker Gillian, O'Neill Suzanne C, Jandorf Lina, Kelly Scott P, Heinzmann Jessica, Kelleher Sarah, Poggi Elizabeth, Schwartz Marc D
Abstract excerpt
PURPOSE: Recent trends indicate increased use of contralateral prophylactic mastectomy (CPM) among newly diagnosed breast cancer patients, particularly those who test positive for a pathogenic variant in the BRCA1/2 genes. However, the rate of CPM among patients who test negative or choose not to be tested is surprisingly high. We aimed to identify patient predictors of CPM following breast cancer diagnosis among...
Topics
- Adult
- Breast Neoplasms
- Clinical Decision-Making
- Combined Modality Therapy
- Disease Management
- Female
- Genes, BRCA1
- Genes, BRCA2
- Genetic Counseling